ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,562Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 19

$1.17M Total Retail Price of All Prescriptions

Rank: 1 out of 19

498 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 498 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

4% of this provider’s 498 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 17,559 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $41 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 31.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 860 774 1 2
FUROSEMIDE 771 731 2 3
TRAZODONE HCL 678 652 3 6
METOPROLOL TARTRATE 673 636 4 10
LEVOTHYROXINE SODIUM 650 575 5 4
CITALOPRAM HBR 596 543 6 12
MIRTAZAPINE 474 465 7 11
LISINOPRIL 463 429 8 5
AMLODIPINE BESYLATE 457 427 9 8
WARFARIN SODIUM 456 303 10 1
LANTUS 425 385 11 31
DONEPEZIL HCL 425 405 11 7
GABAPENTIN 356 295 13 13
SERTRALINE HCL 349 347 14 20
DIVALPROEX SODIUM 316 256 15 18
POTASSIUM CHLORIDE 314 307 16 19
OLANZAPINE 273 244 17 25
NAMENDA 257 254 18 15
QUETIAPINE FUMARATE 249 218 19 22
ABILIFY 240 201 20 39
RISPERIDONE 233 231 21 24
METOPROLOL SUCCINATE 206 194 22 14
CARVEDILOL 192 177 23 37
METFORMIN HCL 178 168 24 17
GLIPIZIDE 160 152 25 34
PREDNISONE 154 143 26 23
HUMALOG 153 135 27 87
DOXYCYCLINE HYCLATE 141 120 28 67
TRAMADOL HCL 140 140 29 27
TAMSULOSIN HCL 137 115 30 29
CYMBALTA 134 119 31 36
CARBIDOPA-LEVODOPA 132 132 32 44
ATORVASTATIN CALCIUM 131 125 33 16
ALENDRONATE SODIUM 130 127 34 32
INSULIN SYRINGE 128 116 35 94
NYSTATIN 125 124 36 58
RAMIPRIL 120 105 37 52
ISOSORBIDE MONONITRATE ER 117 105 38 43
NOVOLIN R 116 100 39 83
CIPROFLOXACIN HCL 111 101 40 85
LATANOPROST 109 108 41 56
BUMETANIDE 100 97 42 73
SINGLE USE SWAB 100 91 42 110
SEROQUEL 96 87 44 41
CLOPIDOGREL 96 89 44 71
PAROXETINE HCL 95 69 46 69
ATENOLOL 94 89 47 21
HYDRALAZINE HCL 90 90 48 90
BENZTROPINE MESYLATE 90 32 R 48 115
HALOPERIDOL 90 72 48 115
NOVOLOG 89 88 51 80
BACLOFEN 89 68 51 65
FLUTICASONE PROPIONATE 88 65 53 49
ADVAIR DISKUS 87 80 54 44
TERAZOSIN HCL 84 76 55 120
FLUOXETINE HCL 82 46 56 64
SPIRONOLACTONE 81 79 57 78
ALBUTEROL SULFATE 80 74 58 122
LIDODERM 79 79 59 40
DIGOXIN 78 78 60 28
OMEPRAZOLE 74 57 61 9
FAMOTIDINE 73 66 62 76
HYDROCODONE-ACETAMINOPHEN 71 58 S3 63 30
SPIRIVA 71 60 63 47
DILTIAZEM 24HR CD 68 68 65 50
ALLOPURINOL 66 66 66 46
CEFTRIAXONE 65 52 67 141
ROPINIROLE HCL 64 54 68 100
LEVOFLOXACIN 61 55 69 79
CLOTRIMAZOLE-BETAMETHASONE 60 52 70 148
GALANTAMINE HBR 59 59 71 150
LAMOTRIGINE 58 57 72 59
CLOZAPINE 57 20 73 62
TOPIRAMATE 57 30 73 158
LITHIUM CARBONATE 57 57 73 158
ESCITALOPRAM OXALATE 57 42 73 48
PHENYTOIN SODIUM EXTENDED 56 32 77 163
IPRATROPIUM-ALBUTEROL 56 55 77 51
HYDROCHLOROTHIAZIDE 56 55 77 26
GENERLAC 55 41 80 167
PLAVIX 55 48 80 167
VENLAFAXINE HCL ER 54 53 82 38
DIVALPROEX SODIUM ER 54 47 82 102
DIOVAN 53 50 84 74
FINASTERIDE 51 38 85 54
METOCLOPRAMIDE HCL 51 51 85 105
NITROFURANTOIN MONO-MACRO 50 45 87 188
ACTOS 50 49 87 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 21, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.